UNITY Biotechnology is developing therapeutics that increase healthspan by preventing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related afflictions such as osteoarthritis, atherosclerosis, eye diseases, and kidney disease.
Market
Healthspan and Aging Therapeutics
Location
San Francisco,
CA,
USA
Coinvestors
ARCH Venture Partners, Baillie Gifford, Fidelity Investments, Mayo Clinic Ventures, Partner Fund Management, Venrock, WuXi PharmaTech